Nicholas D Beyda

Nicholas D Beyda

UNVERIFIED PROFILE

Are you Nicholas D Beyda?   Register this Author

Register author
Nicholas D Beyda

Nicholas D Beyda

Publications by authors named "Nicholas D Beyda"

Are you Nicholas D Beyda?   Register this Author

17Publications

259Reads

37Profile Views

Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

Diagn Microbiol Infect Dis 2019 Nov 5;95(3):114861. Epub 2019 Jul 5.

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M.D. Anderson Cancer Center, Houston, TX, U.S.A.. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07328893193000
Publisher Site
http://dx.doi.org/10.1016/j.diagmicrobio.2019.06.013DOI Listing
November 2019

Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.

J Antimicrob Chemother 2019 Jul;74(7):1904-1910

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkz100DOI Listing
July 2019

Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA.

J Glob Antimicrob Resist 2018 12 26;15:41-47. Epub 2018 May 26.

Department of Pharmacy Practice and Translational Research, Room 4025, University of Houston College of Pharmacy, 4849 Calhoun Road, Houston, TX 77204-5039, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgar.2018.05.015DOI Listing
December 2018

Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy.

J Glob Antimicrob Resist 2018 09 24;14:58-64. Epub 2018 Feb 24.

University of Houston College of Pharmacy, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22137165183004
Publisher Site
http://dx.doi.org/10.1016/j.jgar.2018.02.013DOI Listing
September 2018

Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.

Pharmacotherapy 2017 Nov 2;37(11):1347-1356. Epub 2017 Nov 2.

Department of Pharmacy, Wheaton Franciscan Healthcare - St. Francis Hospital, Milwaukee, Wisconsin.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.2034DOI Listing
November 2017

Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.

Antimicrob Agents Chemother 2015 Sep 22;59(9):5405-12. Epub 2015 Jun 22.

Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.00624-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4538525PMC
September 2015

Echinocandin use in hospitalized patients: a multi-institutional study.

Am J Med Sci 2015 Apr;349(4):316-20

Department of Clinical Sciences and Administration (KWG, SLA, AD, NDB, KK), University of Houston College of Pharmacy, Houston, Texas; Merck & Co, Inc (YX), Whitehouse Station, New Jersey; and Section of Infectious Diseases (HLK), Baylor College of Medicine, Houston Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAJ.0000000000000412DOI Listing
April 2015

Host factors and clinical outcomes of Candida colonization in critically ill patients.

Mycopathologia 2015 Feb 31;179(1-2):87-93. Epub 2014 Aug 31.

University at Buffalo School of Pharmacy and Pharmaceutical Sciences, 313 Kapoor Hall, Buffalo, NY, 14221, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11046-014-9809-6
Publisher Site
http://dx.doi.org/10.1007/s11046-014-9809-6DOI Listing
February 2015

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.

Clin Infect Dis 2014 Sep 30;59(6):819-25. Epub 2014 May 30.

Department of Clinical Sciences & Administration, University of Houston College of Pharmacy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciu407DOI Listing
September 2014

Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples.

Diagn Microbiol Infect Dis 2013 Dec 14;77(4):324-6. Epub 2013 Oct 14.

University of Houston College of Pharmacy, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diagmicrobio.2013.07.007DOI Listing
December 2013

Treatment of Candida famata bloodstream infections: case series and review of the literature.

J Antimicrob Chemother 2013 Feb 19;68(2):438-43. Epub 2012 Oct 19.

University of Houston College of Pharmacy, 1441 Moursund Street, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dks388DOI Listing
February 2013

Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.

Ann Pharmacother 2012 Jul-Aug;46(7-8):1086-96. Epub 2012 Jul 17.

Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1R020DOI Listing
December 2012

Significant publications on infectious diseases pharmacotherapy in 2011.

Am J Health Syst Pharm 2012 Oct;69(19):1671-81

Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp120151DOI Listing
October 2012